natgillin/translations-raw huggingface dataset:
ongoing treatment for HIV infection, since your doctor may want to monitor you more closely.
očasno zdravljenje okužbe s HIV, saj vas bo morda zdravnik spremljal bolj skrbno.
onivyde (liposomal irinotecan) is not equivalent to non-liposomal formulations.
Zdravilo onivyde (liposomski irinotekan) ni enakovredno neliposomskim formulacijam.
ONIVYDE (liposomal irinotecan) is not equivalent to non-liposomal irinotecan formulations and should not be interchanged.
Zdravilo ONIVYDE (liposomski irinotekan) ni enakovredno neliposomskim formulacijam irinotekana, zato jih ne smemo zamenjevati.
ONIVYDE (liposomal irinotecan) must only be prescribed and administered to patients by healthcare professionals experienced in the use of anti-cancer therapies.
Zdravilo ONIVYDE (liposomski irinotekan) smejo bolnikom predpisati in dajati samo zdravstveni delavci, ki imajo izkušnje pri uporabi zdravil za zdravljenje raka.
ONIVYDE 5 mg/ml concentrate for solution for infusion
ONIVYDE 5 mg/ml koncentrat za raztopino za infundiranje
onivyde 5 mg/ml concentrate for solution for infusion Pegylated liposomal irinotecan hydrochloride trihydrate
onivyde 5 mg/ml koncentrat za raztopino za infundiranje pegilirani liposomski irinotekanijev klorid trihidrat
onivyde 5 mg/ml concentrate for solution for infusion Pegylated liposomal irinotecan hydrochloride trihydrate IV use after dilution
onivyde 5 mg/ml koncentrat za raztopino za infundiranje pegilirani liposomski irinotekanijev klorid trihidrat i.v. uporaba po razredčenju
ONIVYDE can cause harm to the foetus when administered to the pregnant woman, as the main ingredient irinotecan has been shown to be embryotoxic and teratogenic in animals (see section 5.3).
Zdravilo ONIVYDE lahko škoduje plodu, če ga jemljejo nosečnice, saj je bila glavna sestavina irinotekan pri živalih dokazano embriotoksična in teratogena (glejte poglavje 5.3).
ONIVYDE contains sodium
Zdravilo ONIVYDE vsebuje natrij
ONIVYDE geomean (95% CI)a
Geometrijsko povprečje zdravila ONIVYDE (95- odstotni IZ)a
ONIVYDE has moderate influence on the ability to drive and use machines.
Zdravilo ONIVYDE ima zmeren vpliv na sposobnost vožnje in upravljanja strojev.
ONIVYDE is a cancer medicine that contains the active substance irinotecan.
Zdravilo ONIVYDE je zdravilo za zdravljenje raka in vsebuje učinkovino irinotekan.
ONIVYDE is a cytotoxic medicinal product and caution should be exercised in handling it.
Zdravilo ONIVYDE je citotoksično zdravilo, zato je pri ravnanju z njim potrebna previdnost.
ONIVYDE is a cytotoxic medicinal product, and caution should be exercised in handling it.
Zdravilo ONIVYDE je citotoksično zdravilo, zato je pri ravnanju z njim potrebna previdnost.
ONIVYDE is a cytotoxic medicinal product.
Zdravilo ONIVYDE je citotoksično.
ONIVYDE is a liposomal formulation of irinotecan with different pharmacokinetic properties compared to non-liposomal irinotecan.
Zdravilo ONIVYDE je liposomska formulacija irinotekana z drugačnimi farmakokinetičnimi lastnostmi, kot jih ima neliposomski irinotekan.
ONIVYDE is for intravenous use.
Zdravilo ONIVYDE je namenjeno za intravensko uporabo.
ONIVYDE is for single use only.
Zdravilo ONIVYDE je samo za enkratno uporabo.
ONIVYDE is given as a drip (infusion) into a vein, which should take at least 90 minutes and should be given as a single dose.
Zdravilo ONIVYDE se daje s kapalno infuzijo (infundiranjem) v veno, kar mora trajati vsaj 90 minut, prejeti pa ga morate v enkratnem odmerku.
ONIVYDE is not equivalent to other non-liposomal irinotecan formulations and should not be interchanged.
Zdravilo ONIVYDE ni enakovredno drugim neliposomskim formulacijam irinotekana, zato jih ne smemo zamenjevati.
ONIVYDE is not recommended for use in adolescents and children below the age of 18 years.
Uporaba zdravila ONIVYDE pri otrocih in mladostnikih, mlajših od 18 let, ni priporočljiva.
ONIVYDE is not recommended for use in patients with severe renal impairment (CLcr < 30 ml/min).
Uporaba zdravila ONIVYDE pri bolnikih s hudo ledvično okvaro (CLcr < 30 ml/min) ni priporočljiva.
ONIVYDE is supplied as a sterile liposomal dispersion at a concentration of 5 mg/ml and must be diluted prior to administration.
Zdravilo ONIVYDE je na voljo kot sterilna liposomska disperzija v koncentraciji 5 mg/ml, ki jo morate pred uporabo razredčiti.
ONIVYDE is supplied as a white to slightly yellow opaque isotonic liposomal dispersion in a glass vial.
Zdravilo ONIVYDE je na voljo kot bela do rumenkasta rahlo motna izotonična liposomska disperzija v stekleni viali.
ONIVYDE is used to treat adult patients with metastatic pancreatic cancer (cancer of the pancreas that has already spread elsewhere in the body) whose previously cancer treatment included a medicine called gemcitabine.
Zdravilo ONIVYDE se uporablja za zdravljenje odraslih bolnikov z metastatskim rakom trebušne slinavke (rakom trebušne slinavke, ki se je že razširil drugje po telesu), ki so se predhodno zdravili zaradi raka z zdravilom, imenovanim gemcitabin.
Onivyde is used together with 5-fluorouracil and leucovorin (two other cancer medicines) in adults whose cancer has got worse despite treatment containing the cancer medicine gemcitabine.
Zdravilo Onivyde se uporablja skupaj s 5-fluorouracilom in levkovorinom (dvema drugima zdraviloma za zdravljenje raka) pri odraslih, pri katerih se je rak poslabšal kljub zdravljenju z gemcitabinom, zdravilom za zdravljenje raka.
ONIVYDE may influence your ability to drive and use machines (as you may be sleepy, dizzy and exhausted with the use of ONIVYDE).
Zdravilo ONIVYDE lahko vpliva na sposobnost upravljanja vozil in strojev (ker ste zaradi uporabe zdravila ONIVYDE lahko zaspani, omotični in izčrpani).
ONIVYDE must not be administered as a bolus injection or an undiluted solution.
Zdravila ONIVYDE ne smete dajati v obliki bolusne injekcije ali nerazredčene raztopine.
ONIVYDE must not be administered to patients with bowel obstruction, and chronic inflammatory bowel disease, until it is resolved.
Zdravila ONIVYDE ne smemo dajati bolnikom z zaporo črevesja ali kronično vnetno črevesno boleznijo, dokler se ta ne pozdravi.
ONIVYDE must not be mixed with other medicinal products except those mentioned in section 6.6.
Zdravila ONIVYDE ne smemo mešati z drugimi zdravili, razen s tistimi, ki so omenjena v poglavju 6.6.
ONIVYDE must not be used instead of other medicines containing irinotecan because it behaves differently when it is contained in the liposomes than when it is given in its free form.
Zdravila ONIVYDE ne smete uporabljati namesto drugih zdravil, ki vsebujejo irinotekan, ker zaprt v liposome deluje drugače kot v prosti obliki.
ONIVYDE should be administered before leucovorin followed by 5-fluorouracil.
Zdravilo ONIVYDE je treba dajati pred lekovorinom, temu pa sledi 5-fluorouracil.
ONIVYDE should be administered before LV followed by 5-FU.
Zdravilo ONIVYDE je treba dajati pred LV, temu pa sledi 5-FU.
ONIVYDE should be discontinued in case of severe hypersensitivitiy reactions.
V primeru hudih preobčutljivostnih reakcij je treba zdravljenje z zdravilom ONIVYDE prekiniti.
ONIVYDE should be discontinued in patients with a confirmed diagnosis of ILD.
Pri bolnikih s potrjeno diagnozo IPB moramo zdravljenje z zdravilom ONIVYDE dokončno prekiniti.
ONIVYDE should be withheld if neutropenic fever occurs or the absolute neutrophil count drops below 1500/mm3.
Dajanje zdravila ONIVYDE je treba odložiti, če se pojavi nevtropenična vročina ali če absolutno število nevtrofilcev pade pod 1.500/mm3.
ONIVYDE should not be administered as a single agent.
Zdravilo ONIVYDE se ne daje kot samostojno zdravilo.
ONIVYDE should not be administered with strong CYP3A4-enzyme inducers such as anticonvulsants (phenytoin, phenobarbital or carbamazepine), rifampin, rifabutin and St. John’s wort unless there are no therapeutic alternatives.
Zdravila ONIVYDE ne smemo dajati skupaj z močnimi induktorji encima CYP3A4, kot so antikonvulzivi (fenitoin, fenobarbital ali karbamazepin), rifampicin, rifabutin in šentjanževka, razen če ni drugih terapevtskih možnosti.
ONIVYDE should not be administered with strong CYP3A4-enzyme inhibitors (e.g. grapefruit juice, clarithromycin, indinavir, itraconazole, lopinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telaprevir, voriconazole).
Zdravila ONIVYDE ne smemo dajati skupaj z močnimi zaviralci encima CYP3A4 (npr. grenivkinim sokom, klaritromicinom, idinavirjem, itrakonazolom, lopinavirjem, nefazodonom, nelfinavirjem, ritonavirjem, sakvinavirjem, telaprevirjem, vorikonazolom).
ONIVYDE should not be administered with strong UGT1A inhibitors (e.g. atazanavir, gemfibrozil, indinavir) unless there are no therapeutic alternatives.
Zdravila ONIVYDE ne smemo dajati z močnimi zaviralci encima UGT1A (npr. atazanavirjem, gemfibrozilom, indinavirjem), razen če ni drugih terapevtskih možnosti.
ONIVYDE with food and drink
Zdravilo ONIVYDE skupaj s hrano in pijačo
ONIVYDE, leucovorin and 5-fluorouracil should be administered sequentially.
Zdravilo ONIVYDE, levkovorin in 5-fluorouracil je treba dajati zaporedno.
ONIVYDE/5-FU adjustment (for patients homozygous for UGT1A1*28 without previous increase to 80 mg/m2)
Prilagajanje odmerka zdravila ONIVYDE/5-FU (pri bolnikih, ki so homozigoti za UGT1A1*28) brez predhodnega zvišanja na 80 mg/m2)
ONIVYDE/5-FU adjustment (for patients not homozygous for UGT1A1*28)
Prilagajanje odmerka zdravila ONIVYDE/5-FU (pri bolnikih, ki niso homozigoti za UGT1A1*28)
ONJ has been reported in the post-marketing setting in patients receiving zoledronic acid for osteoporosis (see section 4.8).
O osteonekrozi čeljusti so poročali pri bolnikih, ki so zaradi osteoporoze prejemali zoledronsko kislino po začetku trženja zdravila (glejte poglavje 4.8).
ONJ has been reported in the post-marketing setting in patients receiving Zoledronic acid Teva Pharma for osteoporosis (see section 4.8).
O osteonekrozi čeljusti so po začetku trženja zdravila poročali pri bolnikih, ki so zaradi osteoporoze prejemali zdravilo Zoledronska kislina Teva Pharma (glejte poglavje 4.8).
ONJ has been reported rarely in patients receiving Prolia for osteoporosis (see section 4.8).
Pri bolnikih, ki so dobivali zdravilo Prolia za osteoporozo, so redko poročali o osteonekrozi čeljustnice (glejte poglavje 4.8).
Only 1 case of pallor associated with the recommended use of Mirvaso was considered to be serious by the MAH.
Imetnik dovoljenja za promet z zdravilom je le za en sam primer bledice, povezan s priporočeno uporabo zdravila Mirvaso, presodil, da je resen.
Only 1 ml should be withdrawn equal to 0.9 mg of thyrotropin alfa.
Odvzeti morate samo 1 ml, kar ustreza 0,9 mg tirotropina alfa.
Only 1.2% of patients exhibited neutralising antibodies (NAb), all of them in the alirocumab group.
Samo pri 1,2 % bolnikov so se pojavila nevtralizirajoča protitelesa (NPt); vsi ti bolniki so bili v skupini z alirokumabom.
Only 10 patients (0.3%) had two or more NAb positive samples.
Samo 10 bolnikov (0,3 %) je imelo dva ali več pozitivnih vzorcev z NPt.
Only 2 patients discontinued treatment early due to this adverse event and one went on to receive additional TRISENOX on a subsequent protocol.
Zaradi tega neželenega učinka so prekinili zdravljenje le pri 2 bolnikih.
Only 22% of the original population of the KLEAN study was enrolled in the study extension
V nadaljevanje študije je bilo vključene le 22 % prvotne populacije študije KLEAN.
Only a clear solution without any particles should be used.
Uporabiti smete le bistro raztopino, brez delcev.
Only a clear solution without any particles should be used.
Uporabiti smete samo bistro raztopino brez delcev.
Only a minor part of the administered radioactivity was excreted as liraglutide­related metabolites in urine or faeces (6% and 5%, respectively).
Samo manjši del aplicirane radioaktivnosti se je v urinu (6 %) ali blatu (5 %) izločil v obliki liraglutidu sorodnih presnovkov.
Only a small number of elderly patients ( 65 years, n=23/872; 2.6 %) provided pharmacokinetic data.
Farmakokinetični podatki so bili pridobljeni le pri manjšem številu starostnikov ( 65 let, n = 23/872; 2,6 %).
Only a small number of patients have received systemic chemotherapy and IT ziconotide.
Le malo bolnikov je prejemalo sistemsko obliko kemoterapije in IT zikonotid.
Only a small proportion of patients included in pivotal clinical trials had severe depression (baseline HAM-D25).
Le majhen delež bolnikov, sodelujočih v presečnih kliničnih preskušanjih, je imel hudo depresijo (izhodiščno število točk po HAM-D  25).
Only a sufficient amount of medicated drinking water should be prepared to cover the daily requirements.
Pripravite le toliko pitne vode z raztopljenim zdravilom, da bo zadostila dnevnim potrebam.
Only a sufficient amount of medicated drinking water should be prepared to cover the daily requirements.
Pripraviti smete le toliko vode za pitje z raztopljenim zdravilom, da bo pokrila dnevne potrebe.
Only after being absorbed by the body is it changed into an active anti- cancer medicine (more in tumour tissue than in normal tissue).
Šele po absorpciji v telesu se spremeni v aktivno citostatično zdravilo (bolj v tumorskem tkivu kot v zdravih tkivih).
Only applicable to outer carton
Podatek je naveden le na škatli.
Only apply REGRANEX to the wound area.
Zdravilo REGRANEX nanesite samo na razjedo.
Only Case or Cohort samples from subjects randomised to either tenofovir disoproxil 245 mg (as fumarate) or Truvada were evaluated for detectable plasma tenofovir levels. b Substudy participants received active adherence monitoring, e.g. unannounced home visits and pill counts, and counselling to improve compliance with study drug.
Samo vzorci študijske skupine ali podskupine od oseb, ki so bile randomizirano izbrane za prejemanje dizoproksiltenofovirata 245 mg (v obliki fumarata) ali zdravila Truvada, so bili ocenjeni glede zaznane koncentracije tenofovirja v plazmi. b Sodelujoči v podštudiji so bili nadzorovani glede aktivne adherence, npr. nenajavljeni domači obiski in štetje tablet.
Only CE marked lamps should be used, equipped with the necessary filters and/or reflecting mirrors to minimize exposure to heat and ultra violet (UV) radiation.
Uporabljajo se lahko samo svetilke z oznako CE, ki so opremljene s potrebnimi filtri in/ali odsevnimi ogledali za zmanjšanje izpostavljenosti toploti in ultravijoličnemu (UV) sevanju.
Only certain CE-marked insulin infusion pumps may be used to infuse insulin lispro.
Za infundiranje insulina lispro lahko uporabljamo samo določene insulinske infuzijske črpalke označene s CE.
Only certain CE-marked insulin infusion pumps may be used to infuse insulin lispro.
Za infundiranje insulina lispro lahko uporabljamo samo določene insulinske infuzijske črpalke, označene s CE.
ONLY check for drop(s) the FIRST TIME you use a new GONAL-f pre-filled pen to remove air in the system.
Konico igle opazujte LE PRVIČ, ko uporabljate nov GONAL-f napolnjeni injekcijski peresnik, da iz sistema odstranite zrak.
Only clear and colourless solutions without particles should be used.
Uporabiti smete samo bistro in brezbarvno raztopino brez delcev.
Only clear and colourless to slightly yellow aqueous solution without visible signs of deterioration should be used.
Uporabljate lahko le bistro in brezbarvno do rumenkasto vodno raztopino brez vidnih znakov kvarjenja.
Only clear solution free from particles and discolouration should be used.
Uporabiti smete samo bistro raztopino brez delcev in nespremenjene barve.
Only clear solution without particles should be used.
Uporabite samo bistro raztopino brez vidnih delcev.
Only clear solutions without particles should be used.
Uporabite lahko samo bistro raztopine brez delcev.
Only clear solutions without particles should be used.
Uporabite lahko samo bistro raztopino brez delcev.
Only clear solutions without particulates should be used.
Uporabite lahko samo bistre raztopine brez vidnih delcev.
Only clear solutions without visible particles should be used.
Uporabite samo bistro raztopino brez vidnih delcev.
Only clear to opalescent solution without particles and without visible signs of deterioration should be used.
Uporabiti smete samo bistro do opalescentno raztopino brez delcev in vidnih znakov kvarjenja.
Only doctors that have been appropriately trained in the correct use of Xiapex and are experienced in the management of Dupuytren’s or Peyronie’s disease are allowed to give you treatment.
Zdravijo vas lahko le zdravniki, ustrezno usposobljeni za pravilno uporabo zdravila Xiapex in z izkušnjami pri obravnavanju Dupuytrenove ali Peyroniejeve bolezni.
Only flocks with no antibodies to MS (M. synoviae) should be vaccinated.
Cepiti je treba samo jate, ki nimajo protiteles za M. synoviae.
Only follow this section when the activation window is white.
Postopke v tem poglavju opravite le, če je aktivacijsko okence belo.
Only fondaparinux can be used to calibrate the anti-Xa assay (the international standards of heparin or LMWH are not appropriate for this use).
Za kalibracijo testa anti- Xa se lahko uporabi samo fondaparinuks (mednarodni standardi heparina ali LMWH za ta namen niso primerni).
Only for NUEDEXTA 15 mg/9 mg: Blister packs consist of a PVC based clear film with aluminium foil seal and contains 13 hard capsules.
Le za zdravilo NUEDEXTA 15 mg/9 mg: Pretisni omot je izdelan iz z prozorne folije na osnovi PVC- ja in iz aluminijaste folije ter vsebuje 13 trdih kapsul.
Only for subcutaneous injection.
Samo za subkutano uporabo.
Only for subcutaneous use
Samo za subkutano uporabo
Only for the blister packs:
Samo za pakiranja s pretisnimi omoti:
Only for the pre-filled syringe with safety device: Important: read the package leaflet before handling syringe.
Samo za napolnjene injekcijske brizge z varnostnim pripomočkom: Pomembno: pred uporabo brizge preberite navodilo za uporabo.
Only handle the syringe by the body, because any contact with the release clips could cause premature release of the safety device.
Injekcijsko brizgo prijemajte le za telo, ker lahko pritisk na sprostitveno sponko sproži pred asno sprostitev varnostnega mehanizma.
Only healthcare professionals with experience of cancer treatments should prescribe and give the medicine.
Zdravilo lahko predpisujejo in dajejo samo zdravniki z izkušnjami v zdravljenju raka.
Only healthy animals should be immunised.
Imunizira naj se samo zdrave živali.
Only healthy animals should be vaccinated.
Cepite samo zdrave živali.
Only healthy cats should be vaccinated.
Cepimo samo zdrave živali.
Only healthy dogs should be vaccinated.
Cepimo samo zdrave pse.
Only healthy horses should be vaccinated.
Cepimo samo zdrave konje.
Only healthy horses should be vaccinated.
Cepimo samo zdrave živali.
Only HIV-HCV co-infected patients were included in the study NR15961 (see Table 20).
V študijo NR15961 so bili vključeni le bolniki, okuženi s HIV in HCV (glejte preglednico 20).
Only in exceptional circumstances, when the anticipated incremental clinical benefit justifies the increased risk of hepatic reactions, should the dose be increased to 200 mg three times daily. (see sections 4.4 and 4.8).
Samo v izjemnih primerih, ko pričakovane zvečane klinične koristi upravičujejo povečano tveganje za poškodbe jeter, naj se odmerek poveča na 200 mg trikrat na dan (glejte poglavje 4.4 in 4.8).
Only in Helicobacter pylori- positive patients does the administration of 45 mg labelled urea lead to a significant increase of 13CO2 in the breath sample within the first 30 minutes.
Samo pri bolnikih, ki so pozitivni na Helicobacter pylori, 45 mg označene sečnine povzroči znatno povečanje 13CO2 v izdihanem zraku v prvih 30 minutah po zaužitju.
Only in Helicobacter pylori-positive patients does the administration of 75 mg labelled urea lead to a significant increase of 13CO2 in the breath sample within the first 30 minutes.
Samo pri bolnikih, ki so pozitivni na Helicobacter pylori, 75 mg označene sečnine povzroči znatno povečanje 13CO2 v izdihanem zraku v prvih 30 minutah po zaužitju.
only includes data on patients who had week 4 HCV RNA available
a vključuje samo podatke o bolnikih, pri katerih je na razpolago podatek o koncentraciji HCV RNK 4. tednu
Only inject one dose per day.
Injicirajte le en odmerek na dan.
Only injection syringes designed for this strength of insulin (100 IU per ml) are to be used.
Uporabljati se sme le injekcijske brizge, namenjene za to koncentracijo insulina (100 i.e./ml).
Only injection syringes designed for this strength of insulin (40 IU per ml) are to be used.
Uporabljati se sme le injekcijske brizge, namenjene za to koncentracijo insulina (40 i.e./ml).
Only keep them if your doctor tells you to.
Obdržite jih samo, če vam je to naročil zdravnik.
Only limited data are available in patients carrying the G551D-CFTR mutation with percent predicted FEV1 (forced expiratory volume exhaled in the first second) of less than 40% (12 patients).
Na voljo so le omejeni podatki za bolnike z mutacijo G551D gena CFTR in napovedanim FEV1 (forsirani ekspiracijski volumen, izdihnjen v prvi sekundi) manjšim od 40 % (12 bolnikov).
Only limited data is available about binding of technetium (99mTc) besilesomab to CarcinoEmbryonic Antigen (CEA) expressing tumours in vivo.
O vezavi tehnecijevega (99mTc) besilesomaba na tumorje, ki izražajo karcinoembrionalni antigen (CEA) in vivo, je podatkov malo.
Only limited pharmacokinetic data are available in patients with severe renal insufficiency (creatinine clearance < 30 ml/min).
Pri bolnikih s težko ledvično insuficienco (očistek kreatinina < 30 ml/min) so na voljo le omejeni farmakokinetični podatki).
Only minor amounts of reteplase were immunologically detected in the urine.
V urinu so imunološko zaznali le manjše količine reteplaze.
Only mix Somavert and the solvent when you are ready to inject your dose.
Zdravilo Somavert in vehikel zmešajte šele, ko ste pripravljeni na injiciranje odmerka.
Only needles that are compatible for use with OptiSet must be used.
Uporabljajte le igle, primerne za uporabo z OptiSetom.
Only needles that are compatible for use with OptiSet must be used.
Uporabljati mora le igle, primerne za uporabo z OptiSetom.
Only needles that are compatible for use with SoloStar should be used.
Bolnik naj uporablja le igle, primerne za uporabo s SoloStarjem.
Only needles that are compatible for use with SoloStar should be used.
Uporabljajte le igle, primerne za uporabo s SoloStarjem.
Only one chewable tablet at a time should be removed from the blister to prevent children from accessing the product.
Iz pretisnega omota je treba vzeti samo eno žvečljivo tableto naenkrat, da se otrokom prepreči dostop do zdravila.
Only one death occurred in each treatment group during the 6-month double-blind study period, therefore no conclusion can be drawn on survival.
V vsaki skupini je v času 6-mesečnega obdobja dvojno slepe študije umrla po ena oseba, zato o preživetju ni mogoče sklepati.
Only one of the 2 spike ports should be used and should not be opened prior to administration in order to avoid contamination.
Uporabi se lahko samo en od 2 vhodov za igle, ki se ga lahko odpre šele pred dajanjem, da se prepreči kontaminacija.
Only one patch is to be worn at a time.
Naenkrat smete uporabljati le en obliž.
Only one patch per day.
Samo en obliž na dan.
Only one transdermal patch is to be worn at a time.
Hkrati se lahko uporablja le en transdermalni obliž.
Only one transdermal patch should be worn at a time.
Hkrati lahko uporablja le po en transdermalni obliž.
Only one vial of Thyrogen is required per injection.
Za vsako injekcijo se uporabi samo ena viala zdravila Thyrogen.
Only patients who are maintained at the 5 microgram dose and who have repeatedly experienced extended inhalation times with Ventavis 10 microgram/ml, which could result in incomplete inhalation, may be considered suitable for switching to Ventavis 20 microgram/ml.
Prehod na zdravilo 20 mikrogramov/ml je primeren le za bolnike, pri katerih se uporablja vzdrževalni odmerek 5 mikrogramov in pri katerih je bil čas inhaliranja zdravila Ventavis 10 mikrogramov/ml zaradi nepopolnih inhalacij večkrat podaljšan.